The Rheumatology Nurses Society is excited to partner with Scipher Medicine to introduce you to PrismRA. This unique and innovative tool utilizes a molecular signature test to inform treatment decisions for patients with rheumatoid arthritis (RA). This new lab test provides insights to help give RA patients their best opportunity to reach treatment goals. With the many options for treating RA available, PrismRA can help narrow down the right one for the individual patient based on their biology.
Join nurse practitioner and RNS Board Member, April Johnson, MSN, APRN, CN, as she goes in depth on PrismRA, how to utilize this tool, and the value behind it!
